Come up with a name for your new list and we'll add to it:
uniQure raised a round of funding on February 16, 2012. Investors include
Forbion Capital Partners.
uniQure is delivering on the promise of gene therapy, single treatments with potentially curative results. The company has developed a modular platform to rapidly bring new disease modifying therapies…